Comments of the Healthcare Supply Chain Association (HSCA) on USTR Request for Comments on the Proposed Modification of Action Pursuant to Section 301
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on the proposed modification of action regarding Chinese exports under Section 301.
Click here for the full comments.
Related Posts
HSCA Statement on House Committee on Homeland Security Hearing on the Coronavirus
March 11, 2020
Washington, DC (March 11, 2020) – Healthcare Supply Chain Association (HSCA)...
HSCA Applauds House Committee on Energy and Commerce for Commitment to Supporting Quality and Protecting Patients from Counterfeit Medical Products
March 11, 2020
Washington, DC (March 11, 2020) – Healthcare Supply Chain Association (HSCA)...
Comments of the Healthcare Supply Chain Association (HSCA) on FDA Request for Comments on the Importation of Prescription Drugs
March 10, 2020
Dear Commissioner Hahn: On behalf of the Healthcare Supply Chain...
HSCA Applauds FDA for Releasing New Data to Enable Generic Competition
June 19, 2019
Washington, DC (June 19, 2019) – Healthcare Supply Chain Association (HSCA)...